Study reveals one simple eating habit that may help boost weight-loss

Losing weight might be as simple as sticking to the meals you know, a new study found.

People who ate the same meals more often lost more weight during a 12-week weight-loss program, according to a new study published in Health Psychology.

"Maintaining a healthy diet in today’s food environment requires constant effort and self-control," lead author Charlotte Hagerman, PhD, of the Oregon Research Institute, said in a statement. 

SIMPLE WEIGHT-LOSS QUIZ MAY PINPOINT WHY SOME DIETS FAIL — AND HOW TO BOOST SUCCESS

"Creating routines around eating may reduce that burden and make healthy choices feel more automatic," she added.

Hagerman and her fellow researchers from Drexel University and the Oregon Research Institute analyzed food logs from 112 adults with overweight or obesity who tracked their meals in an app and weighed themselves daily, according to the study.

The researchers measured "routinized" eating in two main ways: how much participants' daily calorie intake fluctuated and how often they repeated the same meals and snacks over time, according to the paper.

DOCTOR WARNS MANY AMERICANS EAT 'FOOD-LIKE SUBSTANCES,' NOT REAL FOOD

Those whose diets included more repeated foods lost an average of 5.9% of their body weight, compared to 4.3% for those whose eating patterns were more varied, according to a press release from the American Psychological Association.

 People who kept their daily calorie intake more consistent also lost more weight, according to the researchers.

Liza Baker, a Vermont-based nutrition expert and founder of Simply: Health Coaching, said the findings line up with what she has seen firsthand in more than a decade of working with clients.

CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

"Removing the mental load of 'What's for breakfast, lunch or dinner?' can make the wellness journey much more sustainable," Baker told Fox News Digital.

She said repeat meals can reduce decision fatigue and make it easier for people to stick to healthier habits, especially when they are packing lunches, cooking at home and following a simple routine.

Baker said people do not necessarily have to repeat every meal to see benefits.

CLICK HERE FOR MORE HEALTH STORIES

"One can start by eating one meal that is repetitive, usually breakfast or lunch," she said. "As results start to show, it's then more conducive to increasing to two to three repetitive meals a day."

At the same time, experts cautioned that the findings do not prove cause and effect. The study was observational, meaning it found an association between routine eating and greater weight loss, but could not show that repetition alone caused the better results, according to the researchers.

Baker also warned that repeat meal plans can backfire if they are not nutritionally balanced or if they trigger perfectionism.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"Unless someone is well-versed in nutrition, setting up a repeat meal plan can quickly become a nutritional nightmare that leads to becoming deficient in one or more nutrients," she said.

The study authors similarly noted that too little variety could come with trade-offs. Future research is needed to determine whether a more repetitive diet should be actively recommended as a weight-loss strategy, they said.

Fox News Digital reached out to the study's authors for comment.

from Health News Today on Fox News https://ift.tt/AlECvms

Read More

LeAnn Rimes’ emotional reaction to jaw release therapy sparks widespread buzz

Singer LeAnn Rimes has gone viral for her reaction while receiving jaw release therapy.

In a session with Garry Lineham, co-founder of Human Garage in California – a resource for self-healing practices – Rimes received an intra-oral massage, releasing the tension in her jaw. She seemed to instantly feel relief, sobbing on the table.

Jaw release therapy, which involves the massaging or stretching of muscles in the face, is popular for relieving TMJ pain, headaches and jaw clicking, according to experts.

LEANN RIMES BREAKS DOWN INTO TEARS WHILE UNDERGOING 'DEEP JAW RELEASE'

In an interview with Fox News Digital, Lineham shared that stress has an immense impact on human health, especially on muscle tension and pain.

"We hold emotions in our body," he said. "Emotions cause a sympathetic response or a stress response in the body."

"Stress is one thing that impacts every disease, whether it's emotional or physical, whether it is genetic," he went on. "Stress is the thing that makes genetics pop. If you take away stress, those genetic markers no longer express themselves."

STUDY REVEAL WHY CHEWING GUM MIGHT ACTUALLY HELP WITH FOCUS AND STRESS RELIEF

Clenching the jaw can create stress, which happens naturally with physical and emotional exertion, according to Lineham.

"If you clench your jaw and hold it there for three to five minutes … you'll actually fire adrenaline and norepinephrine (hormones and neurotransmitters)," he said.

This sends a message to the body that you’re bracing for an "attack," releasing hormones like stress, Lineham added.

Jaw release therapy targets the fascia, or the connective tissue that supports the body’s muscles, organs and joints. Stretching the fascia also allows the muscle to stretch, providing relief, Lineham said.

"When you release the jaw, then instantaneously you come out of that fight or flight mode," he said. "And if you've been there for a long time, like most people have, it instantaneously shocks the nervous system in a good way."

CLICK HERE FOR MORE HEALTH STORIES

Dr. Justin Richer, oral and maxillofacial surgeon at Riverside Oral Surgery in New Jersey, shared the benefits and risks of jaw release treatment with Fox News Digital.

Certain muscles in the body, such as the shoulder or back, can tense up and "overreact to problems that are going on within them," said the doctor, who did not treat Rimes.

"Jaw release is almost like a massage or similar technique, to put pressure on the muscles and let the tension that's built up just kind of relax away," he said. "It's not something that a lot of people do."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The procedure is most beneficial for those with symptoms of TMJ, facial and muscle pain, and tightness, according to Richer.

Some physical therapists and massage therapists offer this treatment, but Richer recommends seeking help from an oral-facial pain specialist or surgeon who "really understands the anatomy of the jaw joint."

"If it's done properly, there’s very minimal risk," he said. "What we get concerned about is undue manipulation of the joint, so either cracking or distorting or trying to forcefully move the joint … that can actually cause undue harm from an orthopedic perspective."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Despite the benefits, Richer stressed that this kind of therapy may be a temporary fix, as it could be treating only the symptoms of an underlying problem.

"Get a diagnosis first before you go ahead and start manipulating things," he advised.

from Health News Today on Fox News https://ift.tt/31jARHz

Read More

Common drinking habit may quietly triple risk of advanced liver condition

Even occasional binge drinking could triple the risk of a serious liver condition, a new study suggests.

Just one episode per month was associated with a threefold increase in advanced liver fibrosis in people with underlying metabolic liver disease, according to research from the University of Southern California (USC).

Advanced liver fibrosis is a condition that occurs in the advanced stage of chronic liver disease, marked by a buildup of significant scar tissue due to chronic, long-term inflammation, according to the American Liver Foundation.

NEARLY 40% OF CANCERS CAN BE PREVENTED WITH 3 LIFESTYLE CHANGES, STUDY FINDS

Consuming large amounts of alcohol in a short period of time is known to cause liver damage and inflammation, according to medical experts.

"Patients often ask how much they can drink," lead investigator Brian P. Lee, MD, hepatologist and liver transplant specialist with Keck Medicine of USC, told Fox News Digital. "In the liver world, we’re used to thinking about this as an average — for example, we categorize patients based on alcohol consumption per week."

The researchers aimed to determine whether the pattern of drinking affected the risk of liver disease, compared to the total amount consumed.

The study analyzed six years of data from the U.S. National Health and Nutrition Examination Survey (NHANES), which included more than 8,000 adults, according to the study’s press release. 

LITTLE-KNOWN PRESCRIPTION PILL IS HELPING AMERICANS DRINK LESS ALCOHOL

The researchers focused on those with metabolic dysfunction-associated steatotic liver disease (MASLD), which is a fatty liver disease linked to metabolic health problems. 

Most large epidemiologic studies estimate that MASLD affects about 25% to 30% of U.S. adults. The condition is associated with excess weight and obesity, as well as metabolic disorders like type 2 diabetes, high blood pressure and high cholesterol.

More than half of the adults in the study reported occasional heavy drinking, including nearly 16% of those with MASLD. 

Occasional heavy drinking (four or more drinks in one day for women and five or more drinks for men, at least once each month) was linked to at least triple the chance of advanced liver fibrosis, compared to the same amount spread over a longer period of time, the researchers found.

CANNABIS COMPOUNDS COULD REVERSE DISEASE AFFECTING ONE-THIRD OF ADULTS

"The key takeaway is that the pattern matters very much, and episodic heavy drinking is an incredibly common pattern right now among U.S. adults," Lee said.

Younger adults and men were more likely to engage in occasional binge-drinking, the study found. The more drinks consumed during each session, the greater the liver scarring.

The findings were published in the journal Clinical Gastroenterology and Hepatology. 

The pattern of drinking is important, not just the average, Lee noted. "Many patients ask if they don’t drink on weekdays, whether they can drink more on weekends — like a weekly ‘quota’ — and our study is showing that the answer is no," Lee told Fox News Digital.

"This pattern of episodic heavy drinking is especially bad when compared to spreading out alcohol consumption over a longer period of time."

The study did have some limitations, including that it was observational in design and could not prove that binge drinking causes advanced liver fibrosis.

CLICK HERE FOR MORE HEALTH STORIES

It also relied on the participants’ self-reported alcohol consumption, which could be subject to inaccuracies.

Additionally, the findings were primarily linked to people with MASLD and may not apply to all populations.

"This was a cross-sectional study, so longitudinal studies that examine the risk of liver-related events and also potential dynamic drinking would be desirable," Lee said.

"With more than half of adults reporting some episodic heavy drinking, this issue deserves further attention from both physicians and researchers to help better understand, prevent and treat liver disease."

Julian Braithwaite, CEO of the International Alliance for Responsible Drinking, said the study highlights that "how you drink matters."

"Binge drinking is high-risk, even occasionally, but that’s not the same as moderate consumption, which is widely seen as lower risk," he told Fox News Digital. "Not all drinking behaviors are equal, and individual risk matters. The focus should be on helping people avoid harmful patterns and make informed choices."

Dr. Amanda Berger, senior vice president of science and research for the Distilled Spirits Council of the United States, provided the below statement to Fox News Digital. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"The research is clear that alcohol abuse, including excessive and binge drinking, can cause serious health problems. The Distilled Spirits Council recommends that people talk to their health providers to determine what is best for them based on individual risk factors, such as medical conditions, family history and lifestyle."

"Adults who choose to drink should do so moderately, in line with the new Dietary Guidelines for Americans, which recommend adults limit alcohol beverages. The scientific report that informed these recommendations defines moderate drinking as up to one drink per day for women and up to two per day for men."

from Health News Today on Fox News https://ift.tt/OmUG4s9

Read More

Breakthrough ALS study launches as drug aims to slow disease progression

There could be new hope for ALS management as a promising drug enters phase 3 clinical trials.

ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association states. This slowly strips away a person’s ability to walk, talk, eat, dress, write, speak, swallow and, eventually, breathe.

The "PREVAiLS" study, which will review the investigational drug pridopidine as a potential ALS treatment, has already enrolled its first participant, according to a press release from Prilenia Therapeutics and Ferrer, developers of the drug.

ACTOR ERIC DANE'S DEATH FROM ALS SPARKS URGENT FOCUS ON RAPID DECLINE

The first participant has been enrolled at Mass General Brigham under the supervision of Sabrina Paganoni, MD, PhD, co-director of the Mass General Hospital Neurological Clinical Research Institute and lead researcher in the PREVAiLS trial.

"Pridopidine is a sigma-1 receptor (S1R) agonist," Paganoni shared in a statement. "The S1R has been shown to play a role in stimulating multiple neuroprotective pathways impaired in neurodegenerative diseases, such as ALS and Huntington’s disease."

The global clinical trial, which will include 500 participants, aims to evaluate the safety and effectiveness of pridopidine in slowing the progression of ALS in early, rapidly progressive patients. The trial is expected to take place in up to 60 ALS treatment centers across 13 countries.

SELENA GOMEZ SAYS SHE WAS ‘MISDIAGNOSED’ BEFORE RECEIVING BIPOLAR DIAGNOSIS

This is a follow-up to the phase 2 HEALEY ALS Platform Trial results in 2023, which did not reach its main goal of slowing ALS function over the 24-week study period. That research, however, did see positive results in a subgroup of patients who were early in disease and declining rapidly.

In the HEALEY trial, the drug was generally well-tolerated, with a safety profile similar to placebo. The most common adverse events were falls and muscle weakness, which overlap with ALS symptoms.

PREVAiLS is believed to be the only currently recruiting phase 3 ALS study, according to the release.

Phase 3 incorporates "key learnings" from phase 2, Paganoni shared with Fox News Digital, and is expected to determine whether pridopidine is effective as a potential treatment for the disease.

BRAIN IMPLANT ENABLES ALS PATIENT TO COMMUNICATE USING AI

"Enrolling the first participant in this confirmatory study is a milestone in our search for potential new therapeutic options that may help to slow disease progression, preserve function, maintain speech and prolong survival – key aims of early ALS therapy," she said.

"As with all clinical research, definitive conclusions won’t be available until the phase 3 trial is completed and fully analyzed."

Kuldip Dave, PhD, senior vice president of research for The ALS Association in New York City, also commented on the "urgent need" for new ALS treatment options.

"The earlier we can diagnose and treat ALS, the greater the potential to preserve function and maintain quality of life for longer, which is key to making ALS livable until we can cure it," he said in the release.

"It was discouraging to see a lack of overall effect in the phase 2 study population," he said. "However, we were encouraged to see positive signals emerge from various subgroups, including potential impacts on speech and respiratory function." 

CLICK HERE FOR MORE HEALTH STORIES

"Because respiratory decline is a leading cause of ALS morbidity and mortality, even modest preservation of breathing capacity can have a meaningful impact on both quality of life and overall outcomes."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The insights gained from the phase 3 trial will be critical in determining whether these early signals translate into "meaningful, consistent benefits for people with early, rapidly progressing ALS," Dave added.

Dave praised ALS patients for their participation in these studies, along with family members and caregivers for their support. "Participating in ALS research is one of the most powerful ways individuals can contribute to accelerating scientific discovery and making ALS livable until we cure it."

Early signs of the disease include muscle weakness, stiffness and cramping. Symptom progression and severity are different for each case, and the association notes that there is "no single timeline for ALS."

The disease only affects motor neurons controlling voluntary movement, so the five senses — sight, touch, hearing, taste and smell — are not affected, nor are the eye muscles or bladder control.

Diagnosis typically occurs between the ages of 40 and 70. Many ALS patients remain "mentally alert and aware" throughout the disease, The ALS Association reported.

ALS is "always fatal," Dave told Fox News Digital, as most people live only three to five years after diagnosis. About 20% of patients live five years or longer, and only about 5% live longer than 20 years.

There is currently no cure or treatment to stop disease progression.

Prilenia, a Netherlands-based biotech company, shared with Fox News Digital that as neurodegenerative diseases progress, the damage is "irreversible," making them difficult to treat. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"This is why we are focusing on an early, rapidly progressive patient population rather than a broader range of patients, as this provides the best chance of evaluating drug effect within the confines of a time-limited clinical trial," the company stated.

from Health News Today on Fox News https://ift.tt/YhK4BFS

Read More

At least 46 children dead amid measles outbreak as virus spreads globally

Public health officials are warning of measles exposure as the disease spreads on a global scale.

At least 46 children have died in Bangladesh, with about 684 measles cases confirmed in the country since late January, according to Reuters.

Government officials recently announced deaths linked to measles after laboratory testing of 33 samples.

LARGEST MEASLES OUTBREAK IN RECENT HISTORY REPORTED ON SOUTHWESTERN FLORIDA COLLEGE CAMPUS

"Of the tested samples, 15 deaths ⁠have been directly linked to measles infection," said Health Services Division Secretary Kamruzzaman Chowdhury in a statement.

Bangladesh has modified its vaccine schedule after health officials found a significant share of measles cases were occurring in infants younger than 9 months, who are not yet eligible for routine vaccination, according to local reports.

World Health Organization guidance recommends that children receive two doses of the measles, usually given at 9 months of age in countries where measles is common and at 12-15 months in other countries. The second dose should usually be administered at 15-18 months.

CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

In the U.S., as of March 26, 1,575 confirmed measles cases had been reported by the Centers for Disease Control and Prevention.

There have been 16 new outbreaks reported this year, with 94% of confirmed cases deemed outbreak-associated, per the CDC.

The agency attributes the spike in measles activity to a trend of lower "herd immunity" in communities — meaning vaccination rates have fallen below the roughly 95% threshold needed to prevent outbreaks.

"U.S. national MMR coverage among kindergartners has decreased and is now below the 95% coverage target," the CDC states on its website.

Measles symptoms include a high fever, cough, runny nose, watery and red eyes, and a rash that usually appears between three and five days after symptoms start, according to medical sources.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The rash usually begins as flat red spots that appear on the face at the hairline and spread downward to the neck, torso, arms, legs and feet.

CLICK HERE FOR MORE LIFESTYLE STORIES

The airborne virus can spread when someone coughs or sneezes. Measles is known to stay in the air for up to two hours after an infected person leaves the area.

Reuters contributed to this report.

from Health News Today on Fox News https://ift.tt/45Soslc

Read More

RFK Jr launches $134M+ national program to study microplastics in the human body, drinking water

The Department of Health and Human Services (HHS) and the Environmental Protection Agency (EPA) on Thursday announced a massive joint effort to measure, understand and remove microplastics and pharmaceuticals from the nation's water supply and the human body.

HHS Secretary Robert F. Kennedy Jr. and EPA Administrator Lee Zeldin detailed the urgency of the growing health crisis during a press event, citing dramatic increases in plastic concentrations in human organs.

"This is not a rare exposure, this is baseline," Kennedy warned, noting that researchers have found plastic particles in human blood, lung tissue, livers, kidneys and in every single sample of tested human placentas. "We are not dealing with a distant or theoretical risk. We are dealing with a measurable and growing presence inside the human body. And the signal is getting stronger."

He added that the concentration of plastics in the human brain has spiked by 50% since 2016, amounting to roughly "a spoonful of plastic in every human brain."

BANNED CHEMICALS FOUND IN AMERICAN SHAMPOO, SUNSCREEN AND TAMPONS ACROSS MAJOR BRANDS

Kennedy also highlighted a clinical study revealing that patients with microplastics detected in their arterial plaque face a 450% higher risk of heart attack, stroke or death within three years. 

"We do not ignore signals like that," he said. "We investigate."

To tackle the medical crisis, the administration is launching the STOMP (Systematic Targeting of Microplastics) initiative, a national program valued between $134 million and $144 million, which aims to precisely measure microplastics in the body, track how they cause biological harm and safely remove them.

WATCH: PARODY DRUG AD SPOTLIGHTS RFK’S CRACKDOWN ON MISLEADING PHARMACEUTICAL MARKETING

Dr. Alicia Jackson, who leads the Advanced Research Projects Agency for Health, said the program will develop a clinical test for microplastics that takes less than 15 minutes and costs less than $50 so that every American can have access.

"STOMP will do, in five years, what the entire field has been unable to do for decades," Jackson said. "… This field has been working in the dark long enough and STOMP turns on the lights."

On the environmental front, Zeldin announced the release of the draft Sixth Contaminant Candidate List (CCL 6), which includes 75 chemicals, four chemical groups — microplastics, pharmaceuticals, per- and polyfluoroalkyl substances (PFAS), along with disinfection byproducts (DBPs) and nine microbes.

TRUMP ADMIN'S NEW NUTRITION GUIDELINES TARGET ULTRA-PROCESSED FOODS, EASE UP ON RED MEAT AND SATURATED FATS

"For too long, Americans have been ignored as they sound the alarm about plastics in their drinking water. That ends today," Zeldin said. "By placing microplastics on the Contaminant Candidate List, for the first time ever, [the] EPA will follow the science, pursue answers and will hold ourselves to the highest standards to protect the health of Americans."

Additionally, the EPA released human health benchmarks for nearly 400 pharmaceuticals known to, or have the potential to, occur in drinking water — including antibiotics, antidepressants and hormones. 

While the benchmarks are not enforceable regulations, Zeldin described them as a "vital resource" to empower local decision-makers to evaluate risks and protect their communities.

Medical experts at the conference stressed the staggering economic toll of plastic exposure.

"Just from the few chemicals that we know about, the United States health care cost contribution of plastic exposure right now is $250 billion," said Dr. Leonardo Trasande, a pediatrician and director at NYU Grossman School of Medicine. "1.2% of our gross domestic product goes out the window as a result of toxic exposures that derive from plastic. … We're probably underestimating the scope of the problem."

from Health News Today on Fox News https://ift.tt/G95iskQ

Read More

Fatal drug combination sparks alert as 'rhino tranq’ spreads across US

Health and government officials are warning of a potential deadly substance in the illegal drug supply.

The Centers for Disease Control and Prevention (CDC) and the White House Office of National Drug Control Policy (ONDCP) issued a health advisory on Thursday about reports of medetomidine being detected in fentanyl.

Also known as "rhino tranq," "mede" or "dex," medetomidine is a veterinary sedative that causes severe, prolonged sedation. Classified as an alpha-2 agonist, it acts on the nervous system similar to other veterinary sedatives, like xylazine, and can cause life-threatening withdrawal symptoms.

FIRST-OF-ITS-KIND FENTANYL VACCINE TARGETS OVERDOSES BEFORE THEY START

The advisory is based on surveillance data, including forensic drug testing, wastewater analysis, clinical case reports and overdose investigations.

In 2023, there were 247 incidences of medetomidine detected in drug samples, which rose to 2,616 in 2024 and 8,233 in 2025 – a more than 3,000% increase. Forensic drug reports showed that about 98% of medetomidine-positive samples also contained fentanyl. 

The drug has been detected in at least 18 states and Washington, D.C., with a concentration in the Northeast and Midwest regions of the U.S., per the CDC alert.

Dr. Adam Scioli, chief medical officer of Caron Treatment Centers in Pennsylvania, said the alert highlights a "concerning and rapidly evolving development" in the illicit opioid supply.

'GAS STATION HEROIN' BANNED IN ANOTHER STATE AMID NATIONWIDE CRACKDOWNS

"Its co‑occurrence with fentanyl significantly complicates overdose presentation and withdrawal management, further increasing both clinical acuity and unpredictability," he told Fox News Digital.

"Medetomidine is not routinely detected on standard toxicology screens, increasing the risk of under‑recognition without a high index of clinical suspicion."

Naloxone (Narcan), known for its overdose reversal effects, does not counteract medetomidine, the advisory warned.

"While naloxone remains essential for reversing opioid‑induced respiratory depression, it does not address the sedative effects of medetomidine," Scioli confirmed.

CLICK HERE FOR MORE HEALTH STORIES

The initial effects of the drug include deep sedation or decreased consciousness, bradycardia (slow heart rate), hypotension (low blood pressure) and respiratory depression, especially when combined with fentanyl and other opioids.

Withdrawal symptoms typically begin about a few hours after taking medetomidine. They can be severe and rapid, peaking at about 18-36 hours, according to experts.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER 

Initial withdrawal symptoms include rising blood pressure, tachycardia, agitation and nausea/vomiting, gradually leading to severe hypertension, altered mental status, and possible cardiac or neurologic complications, per the alert.

Severe cases require intensive care in a hospital. "Management may require ICU‑level monitoring and care," said Scioli.

In a May 2024 example cited by the CDC, medetomidine in the illegal opioid supply was linked to a cluster of overdoses in Chicago, potentially exceeding 175. At least 16 people were hospitalized and one died.

There were some limitations to the surveillance, the agency acknowledged. Surveillance systems rely on small samples that may not be representative of all areas.

There is also the chance that the numbers could be overestimated due to contamination or repeated use of drug paraphernalia. Conversely, numbers could actually be higher than recorded, as medetomidine is rapidly metabolized in the body and is not typically tested in clinical settings.

The surveillance was conducted by the CDC with support from federal public health programs and collaboration with other agencies.

Scioli noted that the alert highlights the need for "careful assessment beyond standard opioid toxicity models," as well as close coordination with toxicology, emergency medicine and public health partners.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"The drug supply is evolving in ways that strain traditional opioid‑focused frameworks and demand greater clinical vigilance," he said.

"From a treatment perspective, this is another clear example of why addiction care must be adaptive, medically sophisticated, and grounded in whole‑person, long‑term recovery — not solely acute stabilization," he added.

from Health News Today on Fox News https://ift.tt/ZwfMy4i

Read More